BRCA1 and breast cancer: Thus, immune components were analyzed in 3D-TSCs obtained from endogenous mammary tumors derived from genetically engineered mouse model carrying mammary specific disruption of Brca1 (Brca1Co/Co;MMTV-Cre) 35.